The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Vincristine Sulfate 1mg/ml Solution for Injection or Infusion

Pfizer Healthcare IrelandPA0822/232/001

Main Information

Trade NameVincristine Sulfate 1mg/ml Solution for Injection or Infusion
Active SubstancesVincristine sulfate
Dosage FormSolution for injection/infusion
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/232/001

Group Information

ATC CodeL01CA Vinca alkaloids and analogues
L01CA02 vincristine


License statusAuthorised
Licence Issued05/05/1987
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back